|
|
|
Beta Blockers
|
Beta blockers play many roles in the treatment and control of various conditions such as angina, heart failure, high blood pressure, and irregular heartbeats, to name only a few. There are many types of beta blockers available to doctors, and Cath Lab Digest delves deeper into the catheterization processes and cardiac health issues involving beta blockers. |
|
Clinical and Industry News
Clinical and Industry News Industry News: Clinical and Industry News - Lifestyle Changes Can Quickly Reverse Heart Risks In less than a month, individuals can reverse serious heart disease risk factors by making significant lifestyle changes, researchers are reporting. Amiodarone plus beta-blocker significantly reduced (73 percent) the risk of shock compared with beta-blocker alone and sotalol (57 percent reduction). The researchers found that sibling CVD was associated with a 55 percent ...
|
News from the American College of Cardiology meeting (Part II) March 7?10, 2004 New Orleans, Louisiana
Dr. Moses said DIRECT trial findings for in-stent late lumen loss compared favorably with those documented in the SIRIUS trial, which used balloon pre-dilatation (0.18 mm for DIRECT patients versus 0.17 mm for SIRIUS patients). In-stent and in-lesion late loss were 0.20 mm for the insulin-dependent DIRECT trial patients compared with 0.33 mm in-stent late loss and 0.58 mm in-lesion late loss for insulin-dependent SIRIUS trial patients. PAVE and DINAMIT: Clinical Trial Results Evaluate the ...
|
Letters to the Editor
Cath Lab Digest 2004;12(10):39-43. Dear Editor: When I started working cath lab, the MD would pull the balloon and hold for the first 5 minutes and then the RN would take over. Vicki Walston, BSN, RN, VAMC, Minneapolis, MN, walston85@msn.com Re: Rasmussen MR. ?Acute Myocardial Infarction Drug Management.? Ken Gorski, RN, RCIS, FSICP, Cath Lab Digest Editorial Board Member Sones Cardiac Catheterization Labs, The Cleveland Clinic Foundation Cleveland, OH, gorskik@ccf.org The December article ...
|
News from the AHA cont.
- Study Shows Impact of CoregĀ® (carvedilol) on Cardiovascular Risk Factors in Patients With Diabetes and Hypertension Beta-blocker CoregĀ® (carvedilol) may provide advantages in patients with diabetes and hypertension, according to study results released by GlaxoSmithKline. Blood Pressure: Patients on carvedilol reached protocol specified blood pressure goals at a mean daily dose of 35 mg; patients receiving metoprolol tartrate required a mean daily dose of 256 mg to reach protocol-specified ...
|
News from the American College of Cardiology meeting (Part I) March 7?10, 2004 New Orleans, Louisiana
The first was whether statins would be effective in heart attack patients in a hospital setting. Doctors at the hospitals use standardized forms for ordering treatment for their heart attack patients. Heart Patients Undertreated in ER, Despite New Tests Many heart attack patients admitted to the emergency room are going without drugs or surgical procedures that could extend their lives, despite blood test results indicating a need for more aggressive therapy, researchers report.
|
Clinical and Industry News
? The project is made possible by reverse engineering. After treatment, patients?
|
Strategies for Managing the Special Patient in the Catheterization Laboratory
The following article will provide an overview of allergies, anaphylaxis and tips for identifying and treating patients in the cath lab who are at risk for an allergic reaction. Special concerns surrounding the pregnant patient in the lab will be discussed. Finally, informed consent will be addressed, especially as it concerns patients who are not competent or are not able to give consent, such as minors, patients with dementia, and patients who need emergency treatment.
|
Improved Efficiency in Acute Myocardial Infarction Care Through Commitment to Emergency Department Initiated Primary PCI
ABSTRACT: Study objective. Methods. Establishing the clinical and business case for process change.
|
Systemic Anaphylactoid Reactions to Iodinated Contrast Media During Cardiac Catheterization Procedures: Guidelines for prevention, diagnosis, and treatment
This article is reprinted with permission from Catheterization and Cardiovascular Diagnosis 1995;34:99-104.
|
Medical Management is the Only Rational Approach
?Early conservative treatment is not bad. We can effectively manage the majority of unstable angina cases with aggressive medical treatment.?
|
|
|
|
|
|
|
|
On Demand Medical Education
|
|
|
|
|